We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEX icon
1051
Terex
TEX
$7.98B
$327K ﹤0.01%
7,000
– –
PANW icon
1052
Palo Alto Networks
PANW
$264B
$326K ﹤0.01%
1,595
-65
-4% -$12.1K
RDW icon
1053
Redwire
RDW
$2.08B
$324K ﹤0.01%
19,871
+1,000
+5% +$13K
PACK icon
1054
Ranpak Holdings
PACK
$553M
$324K ﹤0.01%
90,680
-320
-0.4% -$1.19K
BELFB
1055
Bel Fuse Inc Class B
BELFB
$3.88B
$319K ﹤0.01%
3,264
– –
FLUT icon
1056
Flutter Entertainment
FLUT
$17.6B
$314K ﹤0.01%
1,100
– –
GKOS icon
1057
Glaukos
GKOS
$9.02B
$310K ﹤0.01%
3,000
– –
GSK icon
1058
GSK
GSK
$103B
$306K ﹤0.01%
7,960
+1,200
+18% +$45.9K
XRX icon
1059
Xerox
XRX
$337M
$306K ﹤0.01%
58,000
+2,500
+5% +$12.2K
UG icon
1060
United-Guardian
UG
$35M
$304K ﹤0.01%
38,000
– –
ALCY
1061
DELISTED
Alchemy Investments Acquisition Corp 1
ALCY
$304K ﹤0.01%
25,900
– –
ENOV icon
1062
Enovis
ENOV
$1.56B
$289K ﹤0.01%
+9,203
New +$304K
DGX icon
1063
Quest Diagnostics
DGX
$25.1B
$287K ﹤0.01%
+1,600
New +$278K
RXO icon
1064
RXO
RXO
$4.23B
$283K ﹤0.01%
18,000
+7,000
+64% +$106K
NFE icon
1065
New Fortress Energy
NFE
$101M
$282K ﹤0.01%
85,000
-37,436
-31% -$163K
SHCO
1066
DELISTED
Soho House & Co
SHCO
$280K ﹤0.01%
38,050
– –
CYTK icon
1067
Cytokinetics
CYTK
$11B
$278K ﹤0.01%
8,410
+1,910
+29% +$66.4K
PCT icon
1068
PureCycle Technologies
PCT
$1.17B
$274K ﹤0.01%
20,000
– –
TEO icon
1069
Telecom Argentina
TEO
$5.89B
$274K ﹤0.01%
31,000
– –
LCII icon
1070
LCI Industries
LCII
$2.51B
$274K ﹤0.01%
3,000
– –
CART icon
1071
Maplebear
CART
$9.92B
$271K ﹤0.01%
6,000
– –
CNC icon
1072
Centene
CNC
$31.3B
$271K ﹤0.01%
5,000
– –
F icon
1073
Ford
F
$57.3B
$271K ﹤0.01%
25,000
-2,500
-9% -$25.5K
SPKL
1074
Spark I Acquisition Corp
SPKL
$103M
$269K ﹤0.01%
24,700
– –
IDXX icon
1075
Idexx Laboratories
IDXX
$42.9B
$268K ﹤0.01%
500
– –
41 42
43
44 45

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.